UCLA's Testicular Cancer Program is multidisciplinary, comprehensive, and focuses on the whole patient. We offer personalized care that includes the latest testicular cancer treatments in surgery, chemotherapy and radiation therapy. The Program is part of the Institute of Urologic Oncology in the UCLA Department of Urology and is affiliated with UCLA's Jonsson Comprehensive Cancer Center. We are committed to a team approach to caring for our patients with testicular cancer. This includes well-coordinated efforts from our urologists, medical oncologists, radiation oncologists, pathologists, radiologists, nurses, and office staff. We also offer mental health support services for patients and their families. All these resources allow for customized perspectives in deciding on the best treatment for each patient. The UCLA Testicular Cancer Program is directed by Dr. Mark Litwin, Professor of Urology and Public Health. Dr. Litwin joined the UCLA faculty in 1993 after training in urologic oncology at Harvard. Dr. Litwin is a longtime testicular cancer survivor himself, so he knows this disease from both sides of the white coat.
UCLA urologist, Dr. Mark S. Litwin, presented a live-streaming webinar to discuss common misconceptions about testicular cancer. He also presented an insider’s view of what to do if you have a lump in the testicle or have been told you have testicular cancer.
What is Testicular Cancer?
Testicular cancer is a disease in which cells become malignant (cancerous) in the male testis (the glands inside the scrotum that produce sperm and male hormones).
It is the most common solid tumor diagnosed in men between the ages of 15 and 34 in the United States. Approximately 8,000 new cases are diagnosed each year, but fewer than 400 men die of the disease each year. Thanks to advances in the treatment of testicular cancer, the prognosis is excellent for most men diagnosed with testicular cancer. When found and treated early, more than 95 percent of men are cured.
The majority of testicular cancers are known as germ cell tumors. These are tumors that begin in undeveloped sperm-producing cells. There are two types of germ cell tumors:
Although there is no known cause, several factors are known to raise a man’s risk. These are:
Meet Our Doctors >
The Department of Urology at UCLA is one of the most progressive and comprehensive urology programs in the country. Our faculty members work side by side with research scientists for new cures and treatments for testicular cancer cancer.